BP Kovatchev, LA Gonder-Frederick, DJ Cox, … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We approach the design of CG-EGA from the
understanding that continuous glucose sensors (CGSs) allow the observation of BG
fluctuations as a process in time. We account for specifics of process ... Cited by 84 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org WL Clarke, S Anderson, L Farhy, M Breton, L … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—FreeStyle Navigator (Abbott Laboratories, Alameda,
CA) and MiniMed CGMS (Medtronic, Northridge, CA) CGSs were applied to the
abdomens of 16 type 1 diabetic subjects (age 42 ± 3 years) 12 h before the ... Cited by 1 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org IM Wentholt, JB Hoekstra, JH DeVries - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—For sensor II, there was a delay between blood glucose and sensed
glucose (7.1 min, P < 0.001). Sensor II was more accurate than sensor I during
hypo- and hyperglycemia (eg, smaller MAD, P = 0.011 and P = 0.024, ... Cited by 19 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org MS Boyne, DM Silver, J Kaplan, CD Saudek - Diabetes, 2003 - Am Diabetes Assoc The objective of this study was to use a subcutaneous continuous glucose sensor
to determine time differences in the dynamics of blood glucose and interstitial
glucose. A total of 14 patients with type 1 diabetes each had two sensors ( ... Cited by 118 - Related articles - BL Direct - All 5 versions
DC Klonoff - Diabetes Care, 2004 - Am Diabetes Assoc Blood glucose monitors are an important tool for people with diabetes to assess
their physiological status and allow them to properly dose themselves with
medication or food. The need to adjust the amount of treatment is greatest ... Cited by 29 - Related articles - BL Direct - All 5 versions
B Feldman, R Brazg, S Schwartz, R Weinstein - Diabetes Technology & Therapeutics, 2003 - liebertonline.com Wired Enzyme™ (Therasense, Alameda, CA) sensing technology for continuous
measurement of in vivo glucose concentrations offers the benefits of (1)
excellent sensor stability, (2) re- duced susceptibility to variations of ... Cited by 71 - Related articles - BL Direct - All 3 versions
GM Steil, K Rebrin, F Hariri, S Jinagonda, S … - Diabetologia, 2005 - Springer Abstract Aims/hypothesis: Glucose sensors often mea- sure sc interstitial fluid
(ISF) glucose rather than blood or plasma glucose. Putative differences between
plasma and ISF glucose include a protracted delay during the recovery from ... Cited by 33 - Related articles - BL Direct - All 3 versions
A Poscia, M Mascini, D Moscone, M Luzzana, G … - Biosensors and Bioelectronics, 2003 - Elsevier The performances and the stability of a novel subcutaneous glucose monitoring
system have been evaluated. GlucoDay® (A. Menarini IFRSrl, Florence Italy) is a
portable instrument provided with a micro-pump and a biosensor coupled to a ... Cited by 33 - Related articles - All 4 versions
- ►diabetesjournals.org E Kulcu, JA Tamada, G Reach, RO Potts, MJ … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—The results show that biographer measures of IG differ in time and
magnitude from the corresponding BG values. In particular, the biographer values
were shifted in time due to instrumental and physiological lag. Results ... Cited by 69 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org A Chico, P Vidal-Ríos, M Subirà, A Novials - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—The CGMS detected unrecognized hypoglycemias in 62.5% of the type 1
diabetic patients and in 46.6% of the type 2 diabetic patients. We found that
73.7% of all events occurred at night. HbA 1c concentrations decreased ... Cited by 121 - Related articles - BL Direct - All 7 versions
